Olverembatinib (HQP1351) in Combination with Lisaftoclax Overcomes Venetoclax Resistance in Preclinical Model of Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Xiong, Yan [1 ]
Liang, Zhiyan [2 ]
Min, Ping [1 ]
Wu, Bingxing [1 ]
Yu, Huidan [1 ]
Yang, Dajun [1 ,2 ,3 ]
Zhai, Yifan [1 ,2 ]
机构：
[1] Ascentage Pharm Suzhou Co Ltd, Suzhou, Peoples R China
[2] Ascentage Pharm Grp Inc, Rockville, MD USA
[3] Sun Yat sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202699
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5777 / 5778
页数：2
相关论文
共 50 条
  • [11] Olverembatinib (HQP1351) Enhances Antitumor Effects of Chemotherapy in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
    Liang, Eric
    Min, Ping
    Xiong, Yan
    Wu, Bingxing
    Yu, Huidan
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2023, 142
  • [12] Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Jabbour, Panelelias
    Kantarjian, Hagop M.
    Koller, Paul B.
    Jamy, Omer
    Oehler, Vivian G.
    Lomaia, Elza
    Hunter, Anthony M.
    Uspenskaya, Olga
    Samarina, Svetlana
    Mukherjee, Sudipto
    Baer, Maria R.
    Zherebtsova, Vera
    Shuvaev, Vasily
    Turkina, Anna
    Davydkin, Igor
    Cortes, Jorge
    Guo, Huanshan
    Chen, Zi
    Fu, Lei
    Wang, Hengbang
    Jiang, Lixin
    Wang, Cunlin
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2023, 142
  • [13] Olverembatinib(HQP1351)-Based Therapy in Adults with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Advanced Chronic Myeloid Leukemia: Results of the Real-Life Study
    Wen, Ziyu
    Fan, Zhiping
    Wang, Qiang
    Zhou, Xuan
    He, Zherou
    Gao, Zicheng
    Chen, Hong
    Liang, Hanyin
    Luo, Dongmei
    Liu, Xiaoli
    Zhou, Hongsheng
    Liu, Qifa
    Xu, Na
    BLOOD, 2023, 142
  • [14] Boanmycin induces apoptosis and overcomes venetoclax resistance in acute myeloid leukemia
    Wang, Jin-Xing
    Zhang, Peng-Wei
    Yuan, Luo-Wei
    Jiang, Jian
    Cheng, Xiao-Hui
    Li, Ju-Heng
    Tang, Mei-Qin
    Fan, Jiao-Yang
    Zhu, Wei
    Lei, Yong
    Tian, Fa-Qing
    ONCOLOGIE, 2024, 26 (05) : 743 - 752
  • [15] Health-Related Quality of Life (HRQOL) in Patients (Pts) with Tyrosine Kinase Inhibitor(TKI)-Resistant Chronic Myeloid Leukemia (CML) Receiving Olverembatinib (HQP1351) Therapy
    Yu, Lu
    Men, Lichuang
    Li, Zongru
    Huang, Xiaojun
    Jiang, Qian
    BLOOD, 2023, 142
  • [16] FMS-like tyrosine kinase 3 (FLT3) inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor APG-2575 in preclinical models of FLT3-mutant acute myeloid leukemia (AML)
    Fang, Douglas D.
    Zhu, Hengrui
    Tang, Qiuqiong
    Wang, Qixin
    Li, Na
    Fang, Xu
    Min, Ping
    Wang, Guangfeng
    Yang, Dajun
    Zhai, Yifan
    CANCER RESEARCH, 2021, 81 (13)
  • [17] Targeting CREB-Binding Protein (CREBBP) Overcomes Resistance to Azacitidine and Venetoclax Therapy in Acute Myeloid Leukemia (AML)
    LeBlanc, Francis
    Bennett, Josh
    Choi, Kwangmin
    Starczynowski, Daniel T.
    BLOOD, 2023, 142
  • [18] Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response
    Sharon, David
    Cathelin, Severine
    Subedi, Amit
    Williams, Ryan
    Benicio, Mariana
    Ketela, Troy
    Chan, Steven M.
    BLOOD, 2017, 130
  • [19] Decitabine in Combination with Venetoclax in Six Elderly Patients with Acute Myeloid Leukemia (AML)
    Rios, Adan
    Kanaan, Zeyad
    Nghia Nguyen
    Rekoff, Gregg
    Chen, Lei
    Wahed, Amer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S211 - S211
  • [20] Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
    Xu, Xi
    Ma, Weiwei
    Qiu, Guo
    Xuan, Li
    He, Chong
    Zhang, Tian
    Wang, Jian
    Liu, Qifa
    BIOLOGY-BASEL, 2023, 12 (10):
12345